Fluxapyroxad belongs to FRAC Group 7 and is a pyrazole-carboxamide-type SDHI fungicide that inhibits succinate dehydrogenase (SDH), thereby disrupting the normal function of complex II in the mitochondrial respiratory chain of pathogens.
This active ingredient possesses systemic activity and can be used for protective management of certain susceptible fungal diseases; it also exhibits some early curative activity depending on the pathogen and the timing of application.
Relevant agricultural applications may include certain foliar diseases of wheat, soybeans, and other crops; however, specific crops and target diseases must be confirmed based on local registered labels.
For importers, the procurement value of fluxapyroxad depends not only on its performance as a single formulation but also on the existing portfolio of SDHI fungicides in the target market.
Since fluxapyroxad belongs to FRAC Group 7 along with boscalid, fluopyram, and pydiflumetofen, there may be a certain risk of cross-resistance among pathogens.
Therefore, simply rotating between different SDHI active ingredients should not be considered a comprehensive resistance management strategy.
Supply Information
MaFa Agro provides supply consulting services for Fluxapyroxad-related products and can coordinate formulation specifications, packaging solutions, brand labels, and technical documentation based on customer needs.
We assist importers in verifying product quality, identifying target disease control needs, and determining bulk purchase terms.